Climacteric E-alert - Volume 20, Number 2;
Langer's insights on the WHI study: unbiased evaluation and behind the scene facts;
Cognitive aging in midlife women: is it real?;
New information technologies in medical practice;
Our Menopause World March 2017;
Risk of recurrent venous thromboembolism in hormone therapy users;
Misclassification rates in breast histopathology biopsies: how can they be lowered?;
Menopause and work;
Cosmetics and women's health;
Endocrine-disrupting chemicals – are they of concern and can we really reduce our exposure;
NAMS Menopause Care;
HRT, dry eyes and other ocular manifestations;
Articles available to Members as well as access to the AMS journal Changes, NAMS First to Know, Congress Abstracts, AGM Minutes, Award Winners and more...
Log on to view.
- Cultural issues in menopause: an exploratory qualitative study of Macedonian women in Australia
- Reducing tooth and gum diseases in postmenopausal women
- Weight loss actually possible after menopause
- Early age menstrual periods increases risk of premature and early menopause
- Helping to head off fractures during menopause
- The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal
- Cardiovascular risk assessment in women – an update
IMS Our Menopause World
IMS Menopause Live
Cognitive aging in midlife women: is it real?
Cognitive aging has become an important issue because of increased life expectancy in women. Cognitive complaints are common during midlife, as part of the climacteric syndrome. By using data from a longitudinal observational s...
New information technologies in medical practice
New information technologies have entered medical practice. The role of the internet has frequently been investigated regarding advantages and disadvantages. In August, Medscape surveyed 1423 health-care providers, including 847 ...
Risk of recurrent venous thromboembolism in hormone therapy users
One of the main issues discussed in relation to postmenopausal hormone therapy (HT) is the risk for venous thromboembolic (VTE) events. In fact, this safety aspect of HT use is probably the only significant one in healthy women younger than 60 or during the first decade of use. A history of VTE usually deters physicians from prescribing HT as these women have anyway a higher risk for recurrent VTE in the future. Is this true also for women who were already using HT when the index VTE occurred?
Misclassification rates in breast histopathology biopsies: how can they be lowered?
Because misclassification of breast biopsies is relatively common, and no prior study had analyzed strategies for reducing error, the recent Elmore study is timely . Here, 12 different strategies for acquiring second opinions were compared in order to help define which strategies worked best to reduce misclassification errors. The authors systematically tested whether and which pathology classification affected the best strategic choice for: invasive breast cancer, ductal carcinoma in situ (DCIS), atypia, proliferative without atypia, or benign without atypia. Also analyzed was the influence of the perceived case difficulty, the pathologists’ clinical volumes, and local institutional policy.
Content Updated April 2017